Alterations in Gut Microbiota by Statin Therapy and Possible Intermediate Effects on Hyperglycemia and Hyperlipidemia

Dysbiosis of the gut microbiota is a contributing factor for obesity-related metabolic diseases such as hyperglycemia and hyperlipidemia. Pharmacotherapy for metabolic diseases involves the modulation of gut microbiota, which is suggested to be a potential therapeutic target. In this study, the modu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Front Microbiol
Hauptverfasser: Kim, Jiyeon, Lee, Heetae, An, Jinho, Song, Youngcheon, Lee, Chong-Kil, Kim, Kyungjae, Kong, Hyunseok
Format: Artigo
Sprache:Inglês
Veröffentlicht: Frontiers Media S.A. 2019
Schlagworte:
Microbiology
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6736992/
https://ncbi.nlm.nih.gov/pubmed/31551944
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmicb.2019.01947
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge